Role of inflammatory mediators in lipid A analogue (ONO-4007)-induced vascular permeability change in mouse skin

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1235-1240

  Ishida, Hiroyasu ^a   Fujii, Emiko ^b   Irie, Kaoru ^b   Yoshioka, Toshimasa ^b   Muraki, Takamura ^b   Ogawa, Ryou ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Endotoxin; Lipid A; Nitric oxide; ONO 4007; Pontamine sky blue; Vascular permeability

Indexed keywords

2 DEOXY 3 O (9 PHENYLNONANOYL) 2 [3 (9 PHENYLNONANOYLOXY)TETRADECANOYLAMINO]GLUCOPYRANOSE 4 SULFATE; AMINOGUANIDINE; ANTIBODY; DIPHENHYDRAMINE; DYE; HISTAMINE; INDOMETACIN; INTERLEUKIN 1ALPHA; LIPID A DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SKIN BLOOD VESSEL;

EID: 0033914138     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703425     Document Type: Article

References (34)

1. AKARASEREENONT, P., MITCHELL, J.A., BAKHLE, Y.S., THIEMERMANN, C. & VANE, J.R. (1995). Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur. J. Pharmacol., 273, 121-128.
2. BALSA, D., MERLOS, M., GIRAL, M., FERRANDO, R., GARCIA-RAFANELL, J. & FORN, J. (1997). Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators. J. Lipid Mediat. Cell Signal., 17, 31-45.
3. BUCHER, M., ITTNER, K.P., ZIMMERMANN, M., WOLF, K., HOBBHAHN, J. & KURTZ, A. (1997). Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipotcichoic acid. FEBS Lett., 412, 511-514.
4. DE WAAL MALEFYT, R., FIGDOR, C.G., HUIJBENS, R., MOHAN-PETERSON, S., BENNETT, B., CULPEPPER, J., DANG, W., ZURAWSKI, G. & DE VRIES, J.E. (1993). Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol., 151, 6370-6381.
5. EDAMITSU, S., MATSUKAWA, A., OHKAWARA, S., TAKAGI, K., NARIUCHI, H. & YOSHINAGA, M. (1995). Role of TNF α, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. Clin. Immumol. Immunopathol., 75, 68-74.
6. FLAD, H.D., LOPPNOW, H., RIETSCHEL, E.T. & ULMER, A.J. (1993). Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology, 187, 303-316.
7. FUJII, E., IRIE, K., OGAWA, A., OHBA, K. & MURAKI, T. (1996). Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol., 297, 257-263.
8. FUJII, E., IRIE, K., OHBA, K., OGAWA, A., YOSHIOKA, T., YAMAKAWA, M. & MURAKI, T. (1997). Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedebergs Arch. Pharmacol., 356, 475-480.
9. FUJII, E., IRIE, K., UCHIDA, Y., OHBA, K. & MURAKI, T. (1995). Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol., 273, 267-272.
10. FUJII, E., IRIE, K., UCHIDA, Y., TSUKAHARA, F. & MURAKI, T. (1994). Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedebergs Arch. Pharmacol., 350, 361-364.
11. GALANOS, C., LUDERITZ, O., RIETSCHEL, E.T., WESTPHAL, O., BRADE, H., BRADE, L., FREUDENBERG, M., SCHADE, U., IMOTO, M., YOSHIMURA, H., KUSUMOTO, S. & SHIBA, T. (1985). Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem., 148, 1-5.
12. GRIFFITHS, M.J., LIU, S., CURZEN, N.P., MESSENT, M. & EVANS, T.W. (1995). In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery. Am. J. Physiol., 268, L509-L518.
13. HATTORI, Y., SZABO, C., GROSS, S., THIEMERMANN, C. & VANE, J.R. (1995). Lipid A and the lipid A analogue anti-tumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo. Eur. J. Pharmacol., 291, 83-90.
14. G-monomethyl-L-arginine or indomethacin. J. Pharmacol. Exp. Ther., 272, 452-459.
15. IUVONE, T., DEN BOSSCHE, R.V., D'ACQUISTO, F., CARNUCCIO, R. & HERMAN, A.G. (1999). Evidence that mast cell dcgranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br. J. Pharmacol., 128, 700-704.
16. KAKU, Y., NANRI, H., SAKIMURA, T., EJIMA, K., KUROIWA, A. & IKEDA, M. (1997). Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells. Biochim. Biophys. Acta, 1356, 43-52.
17. KURAMITSU, Y., NISHIBE, M., OHIRO, Y., MATSUSHITA, K., YUAN, L., OBARA, M., KOBAYASHI, M. & HOSOKAWA, M. (1997). A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-a in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells. Ami-Cancer Drugs, 8, 500-508.
18. LASZLO, F., WHITTLE, B.J., EVANS, S.M. & MONCADA, S. (1995). Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur. J. Pharmacol., 283, 47-53.
19. MATSUMOTO, N., AZE, Y., AKIMOTO, A. & FUJITA, T. (1998). ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-α production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production. J. Pharmacol. Exp. Ther., 284, 189-195.
20. MATSUURA, M., SHIMADA, S., KISO, M., HASEGAWA, A. & NAKANO, M. (1995). Expression of endotoxic activities by synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents. Infection Immunity, 63, 1446-1451.
21. MATUSCHAK, G.M., PINSKY, M.R., KLEIN, E.C., VAN THIEL, D.H. & RINALDO, J.E. (1990). Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am. Rev. Respir. Dis., 141, 1296-1306.
22. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. New Engl. J. Med., 329, 2002-2012.
23. MONCADA, S., PALMER, R.M. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. ,43, 109-142.
24. NAGAI, H., SAKAMOTO, T., INAGAKI, N., MIURA, T. & KODA, A. (1992). The effect of prednisolone on substance P-induced vascular permeability in mice. Agents Actions, 35, 141-148.
25. NATHAN, C.F. (1987). Secretory products of macrophages. J. Clin. Invest., 79, 319-326.
26. RUMBAUT, R.E., HARRIS, N.R., SIAL, A.J., HUXLEY, V.H. & GRANGER, D.N. (1999). Leakage responses to L-NAME differ with the fluorescent dye used to label albumin. Am. J. Physiol., 276, H333-H339.
27. SALVEMINI, D., KORBUT, R., ANGGARD, E. & VANE, J. (1990). Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide [pub-lished erratum appears in Proc Natl Acad Sci USA 1990 Aug; 87(15):6007]. Proc. Natl. Acad. Sci. U.S.A., 87, 2593-2597.
28. SALVEMINI, D., WANG, Z.Q., WYATT, P.S., BOURDON, D.M., MARINO, M.H., MANNING, P.T. & CURRIE, M.G. (1996). Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br. J. Pharmacol., 118, 829-838.
29. SYLVESTER, I., SUFFREDINI, A.F., BOUJOUKOS, A.J., MARTICH, G.D., DANNER, R.L., YOSHIMURA, T. & LEONARD, E.J. (1993). Neutrophil attractant protein-I and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. J. Immunol., 151, 3292-3298.
30. TAKAMATSU, S., NAKASHIMA, I. & NAKANO, K. (1996). Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J. Immunol., 156, 778-785.
31. TAKAYAMA, K., QURESHI, N., BEUTLER, B. & KIRKLAND, T.N. (1989). Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infection Immunity, 57, 1336-1338.
32. TSUCHIYA, S., YAMABE, M., YAMAGUCHI, Y., KOBAYASHI, Y., KONNO, T. & TADA, K. (1980). Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer, 26, 171-176.
33. YANG, D., SATOH, M., UEDA, H., TSUKAGOSHI, S. & YAMAZAKI, M. (1994). Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. Cancer Immunol. Immunother., 38, 287-293.
34. YI, E.S. & ULICH, T.R. (1992). Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules. Am. J. Pathol., 140, 659-663.